[1] WEI L, SUN J, ZHANG N, et al.Noncoding RNAs in gastric cancer: implications for drug resistance[J]. Mol Cancer, 2020, 19(1): 62-79. [2] GULLO I, GRILLO F, MASTRACCI L, et al.Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes[J]. Pathologica, 2020, 112(3): 166-185. [3] SHAN C, ZHANG Y, HAO X, et al.Biogenesis, functions and clinical significance of circRNAs in gastric cancer[J]. Mol Cancer, 2019,18(1): 136-151. [4] GULLO I, GRILLO F, MASTRACCI L, et al.Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes[J]. Pathologica, 2020,112(3): 166-185. [5] SMYTH EC, NILSSON M, GRABSCH HI, et al.Gastric cancer[J]. Lancet, 2020, 396(10251): 635-648. [6] CHEN H, LIANG C, WANG X, et al.The prognostic value of circRNAs for gastric cancer: a systematic review and meta-analysis[J]. Cancer Med, 2020, 9(23): 9096-9106. [7] ZHANG Y, ZHU C, LU X.Advances in serum biomarkers for early diagnosis of gastric cancer[J]. Journal of ZheJiang University Medical Sciences(浙江大学学报医学版), 2019, 48(3): 326-333. [8] WU JY, LEE YC, GRAHAM DY, et al.The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal[J]. Expert Rev Gastroenterol Hepato, 2019, 13(1): 17-24. [9] GULLO I, GRILLO F, MASTRACCI L, et al.Precancerous lesions of the stomach, gastric cancer and hereditary gastric cancer syndromes[J]. Pathologica, 2020, 112(3): 166-185. [10] LI TT, LIU H, YU J, et al.Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells[J]. World J Gastroenterol, 2018, 24(21): 2236-2246. [11] MACHLOWSKA J, BAJ J, SITARZ M, et al.Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies[J]. Int J Mol Sci, 2020, 21(11): 4012-4032. [12] KHATAMI Z, HERDLINGER S, SARKHAIL P, et al.Isolation and characterization of acetylcholinesterase inhibitors from Piper longum and binding mode predictions[J]. Planta Med, 2020, 86(15): 1118-1124. [13] ZHANG L, XIAO Y, YANG R, et al.Systems pharmacology to reveal multi-scale mechanisms of traditional Chinese medicine for gastric cancer[J]. Sci Rep, 2021, 11(1): 22149-22161. [14] LIM HJ, BAK SG, PARK EJ, et al.Retrofractamide C derived from Piper longum alleviates Xylene-Induced mouse ear edema and inhibits phosphorylation of ERK and NF-κB in LPS-induced J774A.1[J]. Molecules, 2020, 25(18): 4058-4069. [15] ABDUBAKIEV S, LI H, LU X, et al.N-alkylamides from Piper longum L. and their stimulative effects on the melanin content and tyrosinase activity in B16 melanoma cells[J]. Nat Prod Res, 2020, 34(17): 2510-2513. [16] WANG RM, YANG HX.Research progress of Piper longum and its effective component Piperine[J]. Chinese Pharmaceutical Affairs(中国药事), 2021, 35(3): 350-356. [17] AMEEN F, ALMANSOB A, AL TAMI M, et al.Epigenetic modifiers affect the bioactive compounds secreted by an endophyte of the tropical plant Piper longum[J]. Molecules, 2021, 26(1): 29-44. [18] HUA S, WANG B, CHEN R, et al.Neuroprotective effect of dichloromethane extraction from Piper nigrum L. and Piper longum L. on permanent focal cerebral ischemia injury in rats[J]. J Stroke Cerebrovasc Dis, 2019, 28(3): 751-760. [19] GUO Z, XU J, XIA J, et al.Anti-inflammatory and antitumour activity of various extracts and compounds from the fruits of Piper longum L.[J]. J Pharm Pharmacol, 2019, 71(7): 1162-1171. [20] ZHANG LL, GU J, ZHONG F, et al.Research progress on modern pharmacology of Piper longum[J]. Chinese Journal of Ethnomedicine and Ethnopharma(中国民族民间医药), 2010, 19(11): 35-36. [21] ZHAO XY, QI QG, BAI YF.Observation of protective effect and pathological changes of Piper longum on cold stress-induced gastric mucosal injury in rats[J]. Chinese Herbal Medicine(中国民族医药杂志), 2004(3): 28. [22] RENQING DZ, FENG XM, LAUSANNE DZ, et al.Network pharmacology combined with molecular docking to study the molecular mechanism of tibetan medicine Liuwei Muxiang Pills in the treatment of gastric cancer[J]. Modernization of Traditional Chinese Medicine and Materia Materia-World Science and Technology(世界科学技术-中医药现代化), 2022, 24(1): 309-319. [23] JIANG ZL, ZHU P, REN Y, et al.Study on anti-gastric cancer mechanism and experiment of compound cili mixture based on network pharmacology[J]. ZheJiang Journal of Integrated Traditional Chinese and Western Medicine(浙江中西医结合杂志), 2022, 32(3): 202-206. [24] LI JH, MO Y, XIA L, et al.Mechanism of arnebia root in treatment of cervical cancer based on network pharmacology and molecular docking technology[J]. Journal of Practical Gynecologic Endocrinology(实用妇科内分泌电子杂志), 2021, 8(11): 10-14. [25] ANSARI S, GANTUYA B, TUAN VP, et al.Diffuse gastric cancer: A summary of analogous contributing factors for its molecular pathogenicity[J]. Int J Mol Sci, 2018, 19(8): 2424-2443. [26] SHAN C, ZHANG Y, HAO X, et al.Biogenesis, functions and clinical significance of circRNAs in gastric cancer[J]. Mol Cancer, 2019, 18(1): 136-151. [27] PAN X, TAO H, NIE M, et al.A clinical study of traditional Chinese medicine prolonging the survival of advanced gastric cancer patients by regulating the immunosuppressive cell population: a study protocol for a multicenter, randomized controlled trail[J]. Medicine (Baltimore), 2020, 99(16): 19757-19762. [28] NAKONIECZNA S, GRABARSKA A, KUKULA-KOCH W.The potential anticancer activity of phytoconstituents against gastric cancer-a review on in vitro, in vitro, and clinical studies[J]. Int J Mol Sci, 2020, 21(21): 8307-8334. [29] HAQ IU, IMRAN M, NADEEM M, et al.Piperine: a review of its biological effects[J]. Phytother Res, 2021, 35(2): 680-700. [30] MANAYI A, NABAVI SM, SETZER WN, et al.Piperine as a potential anti-cancer agent: a review on preclinical studies[J]. Curr Med Chem, 2018, 25(37): 4918-4928. [31] HSIEH HL, YU MC, CHENG LC, et al.Quercetin exerts anti-inflammatory effects via inhibiting tumor necrosis factor-α-induced matrix metalloproteinase-9 expression in normal human gastric epithelial cells[J]. World J Gastroenterol. 2022, 28(11): 1139-1158. [32] HUANG YY, BAI L, LEI XP, et al.Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) knockout and establishment of humanized mouse model[J]. Acta Laboratorium Animalis Scientia Sinica(中国实验动物学报), 2021, 29(2): 137-144. [33] CUI X, ZHANG H, CAO A, et al, Cytokine TNF-α promotes invasion and metastasis of gastric cancer by down-regulating Pentraxin3[J]. J Cancer, 2020, 11(7): 1800-1807. [34] SILVA FFVE, PADÍN-IRUEGAS ME, CAPONIO VCA, et al. Caspase 3 and cleaved caspase 3 expression in tumorogenesis and its correlations with prognosis in head and neck cancer: a systematic review and Meta-analysis[J]. Int J Mol Sci, 2022, 23(19): 11937-12052. [35] ZHOU M, LIU X, LI Z, et al.Caspase-3 regulates the migration, invasion and metastasis of colon cancer cells[J]. Int J Cancer, 2018, 143(4): 921-930. [36] WAN Q, ZHOU J, WU Y, et al.TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathy[J]. Ren Fail, 2022, 44(1): 1216-1226. [37] GAO SY, LI D.Research progress of tumor necrosis factor and cancer[J]. Chinese Pharmacological Bulletin(中国药理学通报), 2020, 36(9): 1209-1213. [38] WANG Z, LIANG X, XIONG A, et al.Helichrysetin and TNFα synergistically promote apoptosis by inhibiting overactivation of the NFκB and EGFR signaling pathways in HeLa and T98G cells[J]. Int J Mol Med, 2021, 47(4): 49-60. [39] FANG Y, XIA HM, SUN J, et al.Effects of TNFα on proliferation and apoptosis of mouse adrenocortical cell line Y1[J]. Journal of Southeast University Medical Science Edition(东南大学学报医学版), 2010, 29(1): 81-85. [40] GONG MJ.Effects of acitretin combined with TNF-α on proliferation and caspase-3 expression of human cutaneous squamous cell carcinoma A431 [D]. Shijiazhuang: Hebei Medical University(河北医科大学), 2012. [41] MIKAMI K, NAGAYA H, GOTOH A, et al.Naftopidil is useful for the treatment of malignant pleural mesothelioma[J]. Pharmacology, 2014, 94(3-4): 163-169. |